Free Trial

Achieve Life Sciences (ACHV) News Today

$5.02
+0.02 (+0.40%)
(As of 03:48 PM ET)
Analysts Offer Predictions for Achieve Life Sciences, Inc.'s Q2 2024 Earnings (NASDAQ:ACHV)
Achieve Life Sciences, Inc. (NASDAQ:ACHV - Free Report) - Analysts at Zacks Small Cap issued their Q2 2024 earnings per share (EPS) estimates for Achieve Life Sciences in a research report issued to clients and investors on Monday, May 13th. Zacks Small Cap analyst J. Vandermosten forecasts that
FY2026 Earnings Estimate for Achieve Life Sciences, Inc. Issued By Zacks Small Cap (NASDAQ:ACHV)
Achieve Life Sciences, Inc. (NASDAQ:ACHV - Free Report) - Investment analysts at Zacks Small Cap issued their FY2026 earnings per share (EPS) estimates for shares of Achieve Life Sciences in a report issued on Monday, May 13th. Zacks Small Cap analyst J. Vandermosten expects that the biopharmaceu
Achieve Life Sciences (NASDAQ:ACHV) Price Target Cut to $11.00
Oppenheimer decreased their price objective on shares of Achieve Life Sciences from $18.00 to $11.00 and set an "outperform" rating for the company in a report on Monday.
Achieve Life Sciences (NASDAQ:ACHV) Receives New Coverage from Analysts at Jonestrading
Jonestrading began coverage on shares of Achieve Life Sciences in a research note on Wednesday. They issued a "buy" rating and a $20.00 price target on the stock.
Achieve Life Sciences (NASDAQ:ACHV) Share Price Crosses Above 200-Day Moving Average of $4.40
Achieve Life Sciences (NASDAQ:ACHV) Stock Price Passes Above 200 Day Moving Average of $4.40
ACHV: 2023 Results
Achieve Life Sciences (NASDAQ:ACHV) Rating Reiterated by Oppenheimer
Oppenheimer reaffirmed an "outperform" rating and issued a $18.00 price target on shares of Achieve Life Sciences in a report on Monday.
Q4 2023 Achieve Life Sciences Inc Earnings Call
Recap: Achieve Life Sciences Q4 Earnings
Achieve Life Sciences (NASDAQ:ACHV) Stock Passes Above Two Hundred Day Moving Average of $4.42
Achieve Life Sciences (NASDAQ:ACHV) Stock Crosses Above 200 Day Moving Average of $4.42
ACHV Apr 2024 2.500 call
Achieve Life Sciences (ACHV) to Release Quarterly Earnings on Thursday
Achieve Life Sciences (NASDAQ:ACHV) will be releasing earnings on Thursday, March 14, Yahoo Finance reports.
How AI Is Saving Lives
Achieve Life Sciences (NASDAQ:ACHV) PT Lowered to $11.00
Lake Street Capital cut their target price on Achieve Life Sciences from $19.00 to $11.00 and set a "buy" rating on the stock in a research report on Tuesday.
ACHV: ORCA-OL to Start 2Q:24
Get Achieve Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACHV and its competitors with MarketBeat's FREE daily newsletter.

Boost your retirement with these AI payouts (Ad)

BREAKING: New "Formula" Could Lead to Huge AI Payouts When you click here and see what Elon Musk's new invention does… Investors — including multiple billionaires — are now tapping into a unique AI secret to pocket huge, consistent payouts.

Starting today, you could siphon a new stream of income from this $3 billion pool of cash.

ACHV Media Mentions By Week

ACHV Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ACHV
News Sentiment

0.86

0.42

Average
Medical
News Sentiment

ACHV News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ACHV Articles
This Week

15

2

ACHV Articles
Average Week

Get Achieve Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACHV and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:ACHV) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners